SynthesisFrontiers in oncology2024

The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis.

Pengfei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.